reviewThe Annual Review of Pharmacology and ToxicologyJan 27, 2004Closed access

DARPP-32: An Integrator of Neurotransmission

Rockefeller University · Kurume University · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Dopamine- and cAMP-regulated phosphoprotein, Mr 32 kDa (DARPP-32), was identified initially as a major target for dopamine and protein kinase A (PKA) in striatum. However, recent advances now indicate that regulation of the state of DARPP-32 phosphorylation provides a mechanism for integrating information arriving at dopaminoceptive neurons, in multiple brain regions, via a variety of neurotransmitters, neuromodulators, neuropeptides, and steroid hormones. Activation of PKA or PKG stimulates DARPP-32 phosphorylation at Thr34 and thereby converts DARPP-32 into a potent inhibitor of protein phosphatase-1 (PP-1). DARPP-32 is also phosphorylated at Thr75 by Cdk5 and this converts DARPP-32 into an inhibitor of PKA.…

Citation impact

722
total citations
FWCI
11.93
Percentile
100%
References
133
Citations per year

Authors

6

Topics & keywords

Keywords
  • Phosphorylation
  • Phosphoprotein
  • Dopamine
  • Protein kinase A
  • Chemistry
  • Protein phosphorylation
  • Neuroscience
  • Pharmacology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.